查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1857781

醫療保健領域量子運算市場：按組件、技術、應用和最終用戶分類－2025年至2032年全球預測

Quantum Computing in Healthcare Market by Component, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療保健領域的量子計算市場規模將達到 23.11 億美元，複合年成長率為 29.88%。

關鍵市場統計數據
基準年 2024 2.8524億美元
預計年份：2025年 3.6451億美元
預測年份 2032 23.11億美元
複合年成長率 (%) 29.88%

對量子計算在醫療保健領域的新興應用以及臨床和商業性應用所需的實際前提條件進行權威說明

量子計算正從理論上的設想走向醫療保健生態系統的實際應用，從根本上改變了我們解決複雜生物學問題的方式。如今，量子運算的研究重點在於降低分子建模中的組合複雜度、加速臨床試驗設計中的最佳化問題以及提升高維度診斷數據中的模式識別能力。這些研究的進展得益於量子位元相干性、誤差緩解技術以及量子-經典混合工作流程的進步。

早期應用通常透過與硬體專家、軟體平台供應商、研究機構和臨床合作夥伴的密切合作來實現。這些努力著重於概念驗證研究、演算法與傳統基準的對比測試，以及在尊重病患隱私的前提下實現演算法訓練的資料管治框架。因此，第一批價值體現在計算複雜性成為瓶頸，並具備將量子計算結果轉化為臨床可操作見解的動態的領域。

然而，量子計算也面臨著許多實際限制，包括硬體的特殊性、與傳統IT系統整合方面的挑戰，以及培養兼具量子理論和生物醫學實踐能力的人才的需求。克服這些限制需要對嚴謹的實驗、標準化的評估指標和可復現的流程進行投入。如果運用得當，量子運算可以提供與現有計算系統互補的能力，從而在不取代現有臨床工作流程的前提下，為發現和診斷開闢新的途徑。

本文簡要概述了技術突破與機構夥伴關係的整合如何重新定義可行性，並加速量子解決方案在醫療保健領域的試點應用。

隨著技術、組織和監管環境的融合，醫療保健領域正經歷顯著的變革，動態解決方案的可行性也日益提高。演算法的改進，特別是誤差感知最佳化和抗雜訊變分法的進步，使得量子處理器在不久的將來更有可能應用於生物醫學領域。同時，硬體架構的成熟也促進了多樣化的實驗，拓展了設計範圍，使其不再局限於超導性量子比特，而是涵蓋了光子學和退火方法，並可根據具體應用需求調整硬體特性。

生態系統的演進也得益於模組化軟體堆疊和特定領域量子套件包的興起，它們彌合了量子原語與生物醫學建模之間的鴻溝。這些軟體進步透過提供更高保真度的開發環境和模擬功能，降低了研究機構和商業團隊的進入門檻。雲端服務供應商、研究型醫院和製藥研發團隊之間的夥伴關係，促進了硬體和專業知識的共用，縮短了從假設到實驗檢驗的回饋週期。

監管機構的關注點也正從理論監督轉向演算法檢驗、資料管理以及模型衍生見解的臨床試驗驗收標準的實用框架。這種監管的成熟，加上旨在進行標準化基準化分析和最佳實踐的合作聯盟，正在改變投資重點並加速試點活動的發展。因此，那些選擇符合臨床需求和監管預期的技術的相關人員，將能夠儘早獲得不對稱優勢。

分析和評估2025年實施的地緣政治貿易措施如何改變了量子賦能醫療保健計畫的供應鏈韌性、籌資策略和合作取得模式。

美國將於2025年加徵關稅，這項措施對量子運算供應鏈產生了多方面的影響，並波及到依賴專用硬體和進口組件的醫療保健主導。關稅帶來的成本壓力增加了關鍵硬體子系統和材料的成本，使得以往依賴國際穩定供應的機構採購時間表變得更加難以預測，促使研究機構和商業實驗室重新評估籌資策略和供應商多元化。

為此，多家研究機構正在加速發展國內供應鏈，加強與本地製造商的夥伴關係，並確保優先取得零件。這種調整促使各方更加重視關鍵零件的國內生產，包括低溫系統、光子組件和精密控制電子設備的製造，從而影響需要專用量子技術接入的醫療保健項目的預算、試驗時間表和資本計劃。

同時，關稅的影響正促使人們重新評估共同研究模式。聯合研究設施、多機構聯盟以及使用雲端基礎海外硬體等方式正被視為降低直接採購成本並保持實驗靈活性的途徑。相關人員正在權衡確保本地部署能力與利用無需長期資本投入的遠端量子服務之間的利弊。重要的是，醫療保健領域的領導者必須明確考慮舉措和貿易政策風險，將其作為動態技術專案進度和成本的先決條件，並在採購和研究夥伴關係協議中納入緊急計畫。

一種細緻入微、主導細分為導向的觀點，將組件堆疊、硬體技術、臨床應用和最終用戶優先級聯繫起來，可以明確量子干涉將在哪些方面創造最大的實際價值。

要了解市場，需要具備細分觀點，將技術選項與臨床應用案例和購買者行為相匹配。依組件分析，市場可分為硬體、服務和軟體；服務可細分為託管服務和專業服務；軟體則可分為量子開發套件、量子程式語言和量子模擬軟體。硬體供應商提供物理基礎，軟體套件提升開發人員的工作效率，而服務則彌合了臨床團隊與技術執行之間的鴻溝。

按技術評估產品可以揭示不同的硬體理念如何解鎖不同的應用領域：基於閘的系統非常適合電路模型實驗和演算法探索；光子處理器為可擴展連接和室溫光子方法提供了途徑；而量子退火則針對那些最有可能在短期內取得優勢的最佳化問題。將這些技術選項映射到應用領域，可以發現機會：臨床試驗最佳化採用退火或混合求解器來解決分配和設計方面的複雜性；藥物發現受益於面向模擬和基於門的分子電子結構方法；基因組和分子建模同時利用模擬軟體和專用開發套件包；醫學影像分析通常將量子啟發式與經典機器學習相結合，以改進模擬軟體和專用開發工具包；醫學影像分析通常將量子啟發式與經典機器學習相結合，以改進從高維影像資料集提取方法的演算法。

從最終用戶的觀點來看，合約研究組織、醫院和診斷中心、製藥和生物技術公司以及研究機構的採用路徑各不相同。合約研究組織通常優先考慮託管服務協議模式，使其能夠在無需購買資本密集型硬體的情況下為申辦方提供新功能。醫院和診斷中心優先考慮經過臨床檢驗且可互通的解決方案，這些方案能夠整合到現有的工作流程和合規體系中。製藥和生物技術公司正在投資於發現和最佳化用例，在這些用例中，動態力學方法可以加速候選化合物的識別，而研究機構則優先考慮探索性實驗和開放科學貢獻。跨領域整合和配對——為特定應用選擇合適的技術並透過合適的服務進行整合——仍然是決定早期成功的關鍵因素。

一項比較區域評估闡明了區域創新生態系統、監管方向和轉化研究能力將如何驅動量子醫療應用的不同採用路徑。

區域動態，反映了人才、資金籌措模式、法律規範和醫療保健系統複雜性方面的差異，正在塑造醫療保健領域動態化應用的步伐和特徵。美洲擁有密集的科學研究叢集、強大的私人投資和靈活的臨床試驗基礎設施。基礎設施投資和龐大的轉化研究機構基礎使該地區成為早期商業性合作的重要培養箱。

在歐洲、中東和非洲，政策協調、國家量子舉措和現有的管理體制正在促進有序部署，強調互通性、倫理監管和跨境學術夥伴關係。統一的標準和共用設施模式對於降低醫院系統和研究機構進行動態方法實驗的進入門檻至關重要。

在亞太地區，各國積極的產業戰略、豐富的人才儲備和大規模的生產能力正在加速硬體的研發和規模化生產。該地區的多個國家正透過政府實驗室、大學和產業界之間的合作投資模式，優先推進將量子研究與具體醫療應用結合的示範計劃。在所有地區，與臨床合作夥伴的接近性以及轉化醫學管道的暢通，都是將實驗成果轉化為臨床應用的關鍵因素。

對常見的企業策略、夥伴關係模式和能力投資進行了深刻的綜合分析，這些策略、模式和投資決定了哪些組織能夠最有效地將實驗室的進步轉化為醫療保健應用。

硬體製造商將專注於提升量子位元品質、系統整合度和可靠性，而軟體供應商則會投資於提高開發人員效率、類比精度和特定領域庫。策略性舉措包括與生命科學機構建立垂直夥伴關係、為分散的研究團隊提供雲端存取硬體，以及創建檢驗的流程，以證明其在典型生物醫學問題上的可複現性。

生態系統參與者正日益組成聯盟和夥伴關係，以共用風險並加速經驗學習。此類合作使製藥公司和受託研究機構能夠在無需長期資本支出的情況下檢驗動態驅動的假設，同時硬體和軟體供應商也能獲得領域回饋，從而完善其產品藍圖。同時，一些供應商正優先考慮認證和合規工作，以降低需要可追溯檢驗路徑的臨床合作夥伴的進入門檻。

投資者和企業發展團隊正在尋找能夠展示轉化Proofpoint、領域專業知識以及在化學、基因組學和最佳化領域客製化演算法方法的可靠知識產權的團隊。因此，那些將深厚的專業知識與紮實的工程實踐和透明的基準基準化分析相結合的組織，最有可能維持夥伴關係，並吸引那些尋求從實驗到營運整合可靠路徑的策略客戶。

這是一套切實可行的策略行動方案和營運保障措施，醫療保健主管、技術供應商和政策制定者應實施這些方案，以安全可靠地採用量子技術。

希望在醫療保健領域充分發揮量子運算價值的領導者應採取務實的分階段方法。他們應先確定計算複雜度構成障礙的高優先級應用場景，在這些場景中，演算法的微小改進就能顯著縮短決策時間並最佳化資源利用。先導計畫應制定明確的成功標準，包括與傳統基準進行可重複性檢定以及設定明確的臨床有效性閾值。

投資於將量子實驗與經典預處理和後處理處理相結合的混合工作流程。加強與學術中心、雲端服務供應商和臨床合作者的策略夥伴關係，以便在無需投入大量資金進行建設的情況下獲取硬體、數據和專業知識。同時，優先發展人才培養夥伴關係，使資料科學家、臨床醫生和工程師掌握將量子輸出轉化為可操作見解所需的互通技能。

從管治角度來看，應儘早實施健全的資料管理和檢驗通訊協定，並積極與監管機構溝通，明確證據要求。為增強採購韌性，應制定供應鏈緊急應變計畫，以因應貿易政策波動，並考慮採用混合籌資策略。最後，應明確知識產權和商業化路徑，以便試點經驗順利推廣應用，避免知識產權糾紛，最終應用於治療藥物開發、診斷服務和營運最佳化等領域。

本文對混合方法、專家檢驗、情境建模和三角測量技術進行了透明的描述，這些技術旨在為量子醫療保健相關人員產生可靠且具有行動導向的見解。

本分析的調查方法結合了定性和定量方法，以確保得出平衡且基於證據的結論。主要研究包括對相關領域專家進行結構化訪談，這些專家包括硬體供應商、軟體架構師、臨床研究人員、監管顧問和採購負責人，以及對同行評審文獻和預印本庫進行技術審查，以檢驗演算法和硬體的相關聲明。次要資訊綜合利用已發表的技術文件、會議論文集和公開的測試結果，繪製出技術發展軌跡並識別可重現的經驗案例。

分析方法包括：透過情境分析探索替代採用路徑；透過技術成熟度評估使設備特性與應用需求相符；以及透過供應鏈映射識別關鍵依賴關係和地緣政治風險因素。研究結果透過多點資料點進行三角驗證，以減少偏差並識別一致模式。限制包括：技術的快速發展可能超越文獻更新周期，且不同組織對專有試點資料的存取權限各不相同，這限制了對特定企業級實施情況的了解。為彌補這些局限性，本研究優先考慮交叉檢驗的案例研究，並尋求獨立專家的佐證。

這種方法論能夠提供可操作的見解，同時保持假設和資料來源的透明度，為策略決策和進一步的有針對性研究提供可靠的基礎。

策略性綜合分析，重點闡述量子運算對醫療保健產生影響的現實、近期機會、必要的組織能力和協作先決條件。

量子運算在醫療保健領域的應用不再是遙不可及的概念，而是一系列新興能力，它有望重新定義發現、最佳化以及部分診斷分析流程。最直接的機會出現在計算複雜性限制當前進展的領域，以及各學科團隊能夠將量子運算能力融入現有決策流程的領域。這項進展將是漸進式的，混合經典-量子解決方案和試驗計畫將為從實驗室演示到臨床應用鋪平道路。

成功與否取決於技術選擇是否與臨床需求相符、對多學科人才的投資，以及建立能夠適應供應鏈和政策變化的彈性採購和夥伴關係模式。採取系統方法、優先考慮可重複性、監管參與和協作實驗的相關人員，將更有能力把技術潛力轉化為營運價值。未來幾年，那些將探索性研究與嚴謹的專案管理相結合，將早期洞見轉化為可擴展能力，從而改善患者療效和營運效率的組織，很可能佔據優勢。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將量子運算和人工智慧結合，實現醫院的即時、精準診斷
  • 對精準醫療日益成長的需求推動了量子運算在醫療保健領域的應用
  • 科技公司和醫療機構擴大合作，加速量子技術的應用。
  • 透過改進數據建模，提高量子計算在個人化治療計劃中的應用。
  • 政府加大對量子技術的投入，這項技術可望徹底改變醫療保健產業。
  • 隨著基因組數據分析變得日益複雜，醫療保健領域對量子運算的需求也日益成長。
  • 時間和成本效率的提升將促進量子演算法在藥物研發中的應用。
  • 由於經典計算的局限性，對量子增強診斷提出了新的需求。
  • 對即時預測分析的需求推動了量子機器學習在醫療保健領域的應用。
  • 醫療保健領域的量子網路安全：因資料隱私擔憂而日益受到關注

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 醫療保健市場中的量子計算組件

  • 硬體
  • 服務
    • 託管服務
    • 專業服務
  • 軟體
    • 量子開發套件
    • 量子程式語言
    • 量子模擬軟體

9. 醫療保健市場中的量子計算技術

  • 大門基地
  • 光子處理器
  • 量子退火

10. 醫療保健市場中的量子計算應用

  • 臨床試驗最佳化
  • 藥物發現
  • 基因組和分子建模
  • 醫學影像分析

第11章 醫療保健市場中的量子計算（按最終用戶分類）

  • 受託研究機構
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究所

12. 各地區醫療保健領域的量子計算市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

13. 醫療保健市場中的量子計算（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國醫療保健領域的量子計算市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Accenture PLC
    • International Business Machines Corporation
    • Amazon Web Services, Inc.
    • Atos SE
    • Classiq Technologies Ltd.
    • D-Wave Quantum Inc.
    • Fujitsu Limited
    • Google LLC by Alphabet Inc.
    • Honeywell International Inc.
    • ID Quantique
    • IonQ, Inc.
    • Microsoft Corporation
    • NVIDIA Corporation
    • PASQAL SAS
    • Protiviti India Member Private Limited
    • QC Ware
    • Quantinuum Ltd.
    • Quantum Xchange
    • Rigetti & Co, LLC
    • SandboxAQ
    • Xanadu Quantum Technologies Inc.
Product Code: MRR-961BA04A2EAA

The Quantum Computing in Healthcare Market is projected to grow by USD 2,311.00 million at a CAGR of 29.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 285.24 million
Estimated Year [2025] USD 364.51 million
Forecast Year [2032] USD 2,311.00 million
CAGR (%) 29.88%

An authoritative orientation to quantum computing's emerging applications in healthcare and the practical prerequisites required for credible clinical and commercial adoption

Quantum computing is transitioning from theoretical promise to pragmatic exploration across the healthcare ecosystem, presenting a fundamental shift in how complex biological problems are approached. Today's quantum initiatives are focused on reducing combinatorial complexity in molecular modeling, accelerating optimization problems in clinical trial design, and improving pattern recognition in high-dimensional diagnostic data. These efforts are informed by advances in qubit coherence, error mitigation techniques, and hybrid quantum-classical workflows that allow near-term devices to contribute meaningfully to domain problems previously considered intractable.

Early deployments are typically undertaken through close collaborations among hardware specialists, software platform providers, research institutions, and clinical partners. These engagements emphasize proof-of-concept studies, algorithm benchmarking against classical baselines, and data governance frameworks that respect patient privacy while enabling algorithmic training. As a result, the first wave of value is emerging in areas where computational complexity is a bottleneck and where domain expertise can translate quantum-generated outputs into clinically actionable insights.

Despite progress, adoption faces practical constraints including hardware idiosyncrasies, integration challenges with legacy IT, and the need for workforce development that spans quantum theory and biomedical practice. Addressing these constraints requires disciplined experimentation, standardized evaluation metrics, and investment in reproducible pipelines. When executed thoughtfully, quantum computing offers a complementary capability that augments existing computational stacks, unlocking new approaches to discovery and diagnostics without displacing established clinical workflows.

A concise synthesis of the converging technological breakthroughs and institutional partnerships that are redefining feasibility and accelerating pilot adoption of quantum solutions in healthcare

The healthcare landscape is experiencing transformative shifts driven by converging technological, organizational, and regulatory dynamics that together increase the feasibility of quantum-enabled solutions. Algorithmic improvements, particularly in error-aware optimization and noise-resilient variational methods, are elevating the utility of near-term quantum processors for applied biomedical tasks. Concurrently, maturation in hardware architectures is widening the design space beyond superconducting qubits to include photonic and annealing approaches, encouraging diversified experimentations that map hardware characteristics to specific application needs.

Ecosystem evolution is also accelerating through the rise of modular software stacks and domain-specific quantum toolkits that bridge the gap between quantum primitives and biomedical modeling. These software advances lower the barrier to entry for research institutes and commercial teams by providing more reproducible development environments and simulation capabilities. Partnerships between cloud providers, research hospitals, and pharmaceutical development teams are enabling shared access to hardware and expertise, which shortens the feedback cycle from hypothesis to experimental validation.

Regulatory attention is similarly shifting from theoretical oversight toward practical frameworks for algorithmic validation, data stewardship, and clinical trial acceptance criteria for model-derived insights. This regulatory maturation, when combined with standardized benchmarking and collaborative consortia for best practices, is reshaping investment priorities and accelerating pilot activity. As a result, stakeholders who align technology choices with clinical need and regulatory expectations are positioned to capture early asymmetric advantages.

An analytical assessment of how geopolitical trade measures enacted in 2025 reshaped supply chain resilience, procurement strategy, and collaborative access models for quantum-enabled healthcare programs

The introduction of United States tariffs in 2025 has produced a layered set of effects across the quantum computing supply chain that ripple into healthcare initiatives that rely on specialized hardware and imported components. Tariff-driven cost pressures on critical hardware subsystems and materials have made procurement timelines less predictable for organizations that previously depended on international supply consistency, prompting research groups and commercial labs to re-evaluate sourcing strategies and vendor diversification.

In response, several organizations have accelerated domestic supply chain development and strengthened partnerships with regional manufacturers to secure priority access to components. This adaptation has increased attention on localizing key portions of the stack, such as cryogenic systems, photonic assemblies, and precision manufacturing for control electronics, which in turn has influenced project budgeting, pilot timelines, and capital planning for healthcare programs that require dedicated quantum access.

At the same time, tariff effects have encouraged a reevaluation of collaborative models: shared research facilities, multi-institution consortia, and cloud-based access to foreign hardware have gained prominence as ways to mitigate direct procurement costs while preserving experimental agility. Stakeholders are balancing the trade-offs between securing on-premises capability and leveraging remote quantum services that can be consumed without long-term capital commitments. For healthcare leaders, the key implication is that timeline and cost assumptions for quantum-enabled initiatives now require explicit consideration of geopolitical and trade policy risks, with contingency planning integrated into procurement and research partnership agreements.

A nuanced segmentation-driven perspective linking component stacks, hardware technologies, clinical applications, and end-user priorities to clarify where quantum interventions create the most practical value

Understanding the market requires a segmentation-aware perspective that maps technical choices to clinical use cases and buyer behavior. When analyzed by component, the landscape separates into hardware, services, and software, with services further subdivided into managed services and professional services, and software distinguishing quantum development kits, quantum programming languages, and quantum simulation software. This layered component view shows where integration effort concentrates: hardware vendors provide the physical substrate, software toolkits deliver developer ergonomics, and services bridge clinical teams to technical execution.

Evaluating offerings by technology highlights how different hardware philosophies unlock different application profiles. Gate-based systems are well-suited to circuit-model experiments and algorithmic exploration; photonic processors provide pathways for scalable connectivity and room-temperature photonic approaches; and quantum annealing targets optimization problems where near-term advantage is most plausible. Mapping these technological choices against application domains clarifies opportunity zones: Clinical Trials Optimization benefits from annealing and hybrid solvers that tackle allocation and design complexity, Drug Discovery aligns with simulation-oriented and gate-based approaches for molecular electronic structure, Genomics & Molecular Modeling leverages both simulation software and specialized development kits, and Medical Imaging Analysis often pairs quantum-inspired algorithms with classical machine learning to improve pattern extraction from high-dimensional imaging datasets.

From an end-user perspective, the adoption pathway differs across Contract Research Organizations, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Institutes. Contract Research Organizations often prioritize managed service engagement models that allow them to offer new capabilities to sponsors without owning capital-intensive hardware. Hospitals and diagnostic centers focus on clinically validated, interoperable solutions that integrate into existing workflows and compliance regimes. Pharmaceutical and biotechnology companies direct investments toward discovery and optimization use cases where quantum methods can accelerate candidate identification, while research institutes emphasize exploratory experimentation and open science contributions. Cross-segmentation alignment-choosing the right technology for the application and packaging it through appropriate services-remains the primary determinant of early success.

A comparative regional assessment explaining how local innovation ecosystems, regulatory orientation, and translational research capacity drive distinct adoption pathways for quantum healthcare applications

Regional dynamics shape the pace and character of quantum adoption in healthcare, reflecting differences in talent, funding models, regulatory frameworks, and healthcare system complexity. In the Americas, concentrated research clusters, strong private investment, and flexible clinical trial infrastructures support rapid pilot cycles and public-private collaborations that test quantum approaches in discovery and optimization contexts. Infrastructure investments and a large base of translational research institutions make this region a primary incubator for early commercial collaborations.

In Europe, Middle East & Africa, policy-driven coordination, national quantum initiatives, and well-established regulatory regimes foster methodical deployments that emphasize interoperability, ethical oversight, and cross-border academic partnerships. Collaboration across jurisdictions in this region often focuses on harmonized standards and shared facility models that lower entry barriers for hospital systems and research organizations seeking to experiment with quantum-enhanced methods.

Asia-Pacific presents a diverse set of trajectories where aggressive national industrial strategies, significant talent pools, and large-scale manufacturing capabilities accelerate hardware development and scale-up. In several countries across this region, co-investment models between government labs, universities, and industry have prioritized demonstrator projects that link quantum research to concrete healthcare applications, particularly where large datasets and strong genomics initiatives provide fertile ground for method validation. Across all regions, proximity to clinical partners and the availability of translational pipelines remain decisive factors in turning experimental successes into clinically relevant outcomes.

An insightful synthesis of prevailing corporate strategies, partnership archetypes, and capability investments that determine which organizations will most effectively bridge laboratory advances to healthcare applications

Company strategies coalesce around complementary roles: hardware manufacturers focus on improving qubit quality, system integration, and reliability; software providers invest in developer productivity, simulation fidelity, and domain-specific libraries; and service organizations specialize in bridging clinical questions to technical proofs of concept. Strategic behaviors include pursuing vertical partnerships with life sciences organizations, enabling cloud-accessible hardware to reach distributed research teams, and creating validated pipelines that demonstrate reproducibility on representative biomedical problems.

Ecosystem participants are increasingly forming consortiums and pilot partnerships to share risk and accelerate empirical learning. These collaborative arrangements allow pharmaceutical companies and contract research organizations to test quantum-derived hypotheses without committing to long-term capital expenditure, while hardware and software vendors gain domain feedback to refine product roadmaps. In parallel, some vendors are prioritizing certification and compliance efforts to lower barriers for clinical partners that require traceable validation pathways.

Investors and corporate development teams are attentive to teams that can demonstrate translational proof points, domain expertise, and defensible IP in algorithmic approaches tailored to chemistry, genomics, or optimization. As a result, organizations that combine deep domain knowledge with robust engineering practices and transparent benchmarking are the most likely to sustain partnerships and attract strategic customers seeking credible paths from experimentation to operational integration.

A pragmatic portfolio of strategic actions and operational guardrails that healthcare executives, technology vendors, and policymakers should implement to accelerate secure, measurable adoption of quantum-enabled capabilities

Leaders seeking to capture value from quantum computing in healthcare should pursue a pragmatic, staged approach that balances ambition with operational realism. Begin by identifying priority use cases where computational complexity is a demonstrable barrier and where modest algorithmic improvements could materially change decision timelines or resource utilization. Pilot projects should be scoped with explicit success criteria, including reproducibility checks against classical baselines and clear thresholds for clinical relevance.

Invest in hybrid workflows that combine quantum experimentation with classical pre- and post-processing; this reduces risk and creates immediate value while quantum hardware matures. Strengthen strategic partnerships with academic centers, cloud service providers, and clinical collaborators to gain access to hardware, data, and domain expertise without fully committing to capital-intensive builds. Simultaneously, prioritize workforce development programs that equip data scientists, clinicians, and engineers with interoperable skills required to translate quantum outputs into actionable insights.

From a governance perspective, implement robust data stewardship and validation protocols early, and engage proactively with regulators to clarify evidence expectations. For procurement resilience, incorporate supply chain contingency planning that accounts for trade policy volatility and consider mixed sourcing strategies. Finally, establish clear intellectual property and commercialization pathways so that pilot learnings can scale into therapeutic development, diagnostic services, or operational optimization without intellectual friction.

A transparent explanation of the mixed methods, expert validation, scenario modeling, and triangulation techniques used to produce reliable, action-oriented insights for quantum healthcare stakeholders

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure balanced, evidence-based conclusions. Primary research included structured interviews with subject-matter experts spanning hardware vendors, software architects, clinical investigators, regulatory advisors, and procurement officers, complemented by technical reviews of peer-reviewed literature and preprint archives to validate algorithmic and hardware claims. Secondary source synthesis drew on open technical documentation, conference proceedings, and publicly disclosed pilot results to map developmental trajectories and identify reproducible demonstrations.

Analytical methods incorporated scenario analysis to explore alternative adoption pathways, technology maturity assessments to align device characteristics with application requirements, and supply chain mapping to identify critical dependencies and geopolitical risk vectors. Findings were triangulated across multiple data points to reduce bias and identify consistent patterns. Limitations are acknowledged: rapid technical evolution can outpace literature cycles, and access to proprietary pilot data varies across organizations, which constrains visibility into certain enterprise-scale implementations. To mitigate these constraints, the research prioritized cross-validated examples and sought corroboration from independent experts.

This methodological approach enables actionable insights while maintaining transparency about assumptions and data provenance, providing a defensible basis for strategic decisions and further targeted investigation.

A strategic synthesis emphasizing the realistic near-term opportunities, necessary organizational capabilities, and collaborative prerequisites required to convert quantum promise into healthcare impact

Quantum computing in healthcare is no longer a distant concept but a set of emerging capabilities with the potential to redefine portions of discovery, optimization, and diagnostic analytics. The most immediate opportunities arise where computational intensity constrains progress today and where domain teams can integrate quantum outputs into established decision processes. Progress will be uneven and incremental, with hybrid classical-quantum solutions and curated pilot programs paving the route from laboratory demonstrations to clinically relevant applications.

Success depends on aligning technology selection to clinical need, investing in cross-disciplinary talent, and building resilient procurement and partnership models that can adapt to supply chain and policy changes. Stakeholders that take a methodical approach-prioritizing reproducibility, regulatory engagement, and collaborative experimentation-will be best positioned to translate technical promise into operational value. The coming years will favor organizations that combine curiosity-driven research with disciplined program management, allowing them to convert early insights into scalable capabilities that improve patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of quantum computing and AI enabling real-time precision diagnostics in hospitals
  • 5.2. Adoption of quantum computing in healthcare due to growing demand for precision medicine
  • 5.3. Growing collaboration between tech companies and healthcare institutions to accelerate quantum adoption
  • 5.4. Increasing use of quantum computing for personalized treatment planning due to better data modeling
  • 5.5. Surging government funding in quantum technologies due to their transformative potential in healthcare
  • 5.6. Increasing need for quantum computing in healthcare due to rising complexity of genomic data analysis
  • 5.7. Increased use of quantum algorithms in drug discovery due to time and cost efficiencies
  • 5.8. Emerging demand for quantum-enhanced diagnostics due to limitations of classical computing
  • 5.9. Adoption of quantum machine learning in healthcare due to the need for real-time predictive analytics
  • 5.10. Growing focus on quantum cybersecurity in healthcare due to data privacy concerns

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Quantum Computing in Healthcare Market, by Component

  • 8.1. Hardware
  • 8.2. Services
    • 8.2.1. Managed Services
    • 8.2.2. Professional Services
  • 8.3. Software
    • 8.3.1. Quantum Development Kits
    • 8.3.2. Quantum Programming Languages
    • 8.3.3. Quantum Simulation Software

9. Quantum Computing in Healthcare Market, by Technology

  • 9.1. Gate Based
  • 9.2. Photonic Processors
  • 9.3. Quantum Annealing

10. Quantum Computing in Healthcare Market, by Application

  • 10.1. Clinical Trials Optimization
  • 10.2. Drug Discovery
  • 10.3. Genomics & Molecular Modeling
  • 10.4. Medical Imaging Analysis

11. Quantum Computing in Healthcare Market, by End User

  • 11.1. Contract Research Organizations
  • 11.2. Hospitals & Diagnostic Centers
  • 11.3. Pharmaceutical & Biotechnology Companies
  • 11.4. Research Institutes

12. Quantum Computing in Healthcare Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Quantum Computing in Healthcare Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Quantum Computing in Healthcare Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Accenture PLC
    • 15.3.2. International Business Machines Corporation
    • 15.3.3. Amazon Web Services, Inc.
    • 15.3.4. Atos SE
    • 15.3.5. Classiq Technologies Ltd.
    • 15.3.6. D-Wave Quantum Inc.
    • 15.3.7. Fujitsu Limited
    • 15.3.8. Google LLC by Alphabet Inc.
    • 15.3.9. Honeywell International Inc.
    • 15.3.10. ID Quantique
    • 15.3.11. IonQ, Inc.
    • 15.3.12. Microsoft Corporation
    • 15.3.13. NVIDIA Corporation
    • 15.3.14. PASQAL SAS
    • 15.3.15. Protiviti India Member Private Limited
    • 15.3.16. QC Ware
    • 15.3.17. Quantinuum Ltd.
    • 15.3.18. Quantum Xchange
    • 15.3.19. Rigetti & Co, LLC
    • 15.3.20. SandboxAQ
    • 15.3.21. Xanadu Quantum Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. QUANTUM COMPUTING IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. QUANTUM COMPUTING IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. QUANTUM COMPUTING IN HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM DEVELOPMENT KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM PROGRAMMING LANGUAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM SIMULATION SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GATE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHOTONIC PROCESSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY QUANTUM ANNEALING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CLINICAL TRIALS OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GENOMICS & MOLECULAR MODELING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 264. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 265. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 266. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 267. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. GCC QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS QUANTUM COMPUTING IN HEALTHCARE MARKET S